hotspot -WSS

hotspot

author：Wikipedia 2025-09-30 18:21:03 - browse：36236

LONDON — Seeking to build up its pharma business, the Japanese conglomerate Asahi Kasei is moving to buy Swedish biotech Calliditas Therapeutics in a nearly $1.1 billion cash deal, the companies said Tuesday.

The firm’s offer of $19.68 per share amounts to an 83% premium versus Calliditas’ closing price on a Swedish exchange Monday. The Calliditas board has unanimously recommended that shareholders accept the offer, the company said, adding that it “aims to realize the benefits of being part of a larger platform” by being acquired.

Calliditas has an approved drug on the U.S. market called Tarpeyo, which treats a kidney disease called IgA nephropathy. The condition has in recent years attracted interest from a number of pharma companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Biden declares emergency in flood

hotspot

entertainment

WSS

Parents surprise family after baby discharged from NICU after 170 days

$1 billion proposal to grow Boston, Massachusetts biotech

Biden’s NIH nominee is languishing in Congress

Ancient Greek ideas underpin modern concepts of pregnancy

Florida health officials providing scant details on measles cases

The public health thinking behind the CDC’s new Covid guidance

entertainment

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Biden’s NIH nominee is languishing in Congress

Malaria cases in Florida and Texas: Here’s what you need to know

Recent heat wave in the Mediterranean caused by climate change: Study

Malaria cases in Florida and Texas: Here’s what you need to know

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

The cancer drug shortage isn’t new — and neither are the solutions

Stem cell biologist probes earliest stages of human development

23andMe had bad news about my health. I wish a person had delivered it

Microsoft's Peter Lee: Generative AI could help doctors be more human

knowledge

White House announces new plan to address the growing threat of xylazine in overdose crisis

Medicare drug price negotiation continues, as pharma counteroffers

Wisconsin governor employs partial veto to fund schools for 4 centuries

White House announces new plan to address the growing threat of xylazine in overdose crisis

For AI in health care standards, federal regulators join with industry group

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

hotspot

entertainment

entertainment

explore